This is a novel approach for patients with very advanced melanoma. It is applicable to those patients who test positive for the B-RAF gene.
Targeted therapy may prove helpful for melanoma and a number of other cancers. The NY Times has a three part article on this promising new therapy. It is a bit long and perhaps overly sensational, but it is a good introduction to this area.
Part 1. Doggedly Testing a Melanoma Drug by Amy Harmon.
Part 2. After Long Fight, Drug Gives Sudden Reprieve by Amy Harmon.
Part 3. A Drug Trial Cycle: Recovery, Relapse, Reinvention by Amy Harmon
.